Evidence explainerGLP-1 Companion
Hair Shedding on a GLP-1: Why It Starts Months Later, Whether It Grows Back, and the Ferritin Question
Shedding linked to weight loss is usually telogen effluvium, which is typically reversible: a 2026 review says regrowth tends to become noticeable within 6 to 12 months once the trigger is removed or treated. Iron is recommended when tests show iron-deficiency anemia; its value for shedding otherwise is debated.
Key takeaways
- Zepbound’s label ties hair loss in its trials to weight reduction and reports it in 7.1% of women vs 0.5% of men on the drug [2].
- Wegovy’s label reports hair loss in 3.3% of adults on 2.4 mg and 5.8% on the 7.2 mg dose, vs about 1% on placebo, again mostly in women [3].
- In telogen effluvium, hairs enter the resting phase early and fall out about 3 months later; it is typically reversible, with regrowth usually noticeable within 6 to 12 months once the trigger is removed or treated [1].
- A 2026 meta-analysis found GLP-1 users had about 40% higher odds of non-scarring hair loss, driven by telogen effluvium and pattern hair loss [5].
- Iron supplements are recommended for iron-deficiency anemia; their use without anemia is controversial [1].
How common it is
In Zepbound’s pooled weight-loss trials, hair loss was associated with weight reduction and was reported in 7.1% of women vs 0.5% of men on tirzepatide (1.3% vs 0% on placebo); no one on tirzepatide stopped because of it [2].
Wegovy’s current label reports hair loss in 3.3% of adults on 2.4 mg (4% of women, 0.9% of men) vs 1% on placebo, and in 5.8% on the higher 7.2 mg dose in its trials (8.4% of women, 0.2% of men) [3]. A 2026 systematic review found semaglutide and tirzepatide had the highest reported rates among GLP-1 drugs, with females disproportionately affected [4].
Why shedding shows up months later
About 90% of scalp follicles are normally growing and about 10% resting; a resting hair falls out after about 3 months, and shedding 50 to 150 hairs a day is normal [1]. Telogen effluvium happens when a stress pushes more follicles into the resting phase early, so the shedding trails its trigger [1].
Recognized triggers include diets for rapid weight loss, eating too little protein or too few calories, and low iron, zinc or vitamin D [1]. The 2026 systematic review found rapid weight loss a likely contributor, with tirzepatide most often linked to telogen effluvium and semaglutide hair loss appearing dose-dependent [4].
Does it grow back?
Telogen effluvium is nonscarring and causes temporary shedding, not complete hair loss; a 2026 Cleveland Clinic review says regrowth typically becomes noticeable within 6 to 12 months once the trigger is removed or treated [1]. The same review says minoxidil is not routinely recommended for acute telogen effluvium [1].
Shedding can also be the first sign of hereditary pattern hair loss, which keeps progressing unless treated, so thinning that persists deserves a clinician’s look [1]. The authors of the 2026 meta-analysis advise against stopping GLP-1 treatment prematurely over hair loss [5]; see what happens to weight when people stop in stopping a GLP-1.
Iron and ferritin
The review lists a blood count, metabolic panel, thyroid test and ferritin as screening labs for shedding without a clear cause [1]. Iron is recommended for iron-deficiency anemia; without anemia it is controversial, though some clinicians aim to keep ferritin in the upper part of the normal range based on experience [1].
The studies are mixed. In a 2003 study, mean ferritin was lower than in women without hair loss among women with pattern hair loss and alopecia areata, but not significantly lower in telogen effluvium [7]. In a 2010 study of 457 women, iron deficiency was common but not more frequent in chronic telogen effluvium or pattern hair loss than in controls [6]. See our iron monograph and test before taking iron.
What to raise with your clinician
Points worth bringing up:
- How fast you are losing weight and whether dose increases line up with the shedding [4].
- Your protein and calorie intake if appetite is very low [1]; see protein targets on a GLP-1.
- Whether a blood count, ferritin and thyroid test make sense [1].
- Shedding or thinning that persists, which may point to pattern hair loss [1].
Quick answers
Is GLP-1 hair loss permanent?
Telogen effluvium is nonscarring and typically reversible [1]. Shedding can unmask hereditary pattern hair loss, which needs its own treatment [1].
How long until hair grows back?
A 2026 review says regrowth typically becomes noticeable within 6 to 12 months once the trigger is removed or treated [1].
Do biotin or zinc help shedding?
Without a deficiency, the benefit of supplements such as zinc, biotin or vitamin D is unclear [1].
More in GLP-1 Companion
- GLP-1 Companion hub
- Muscle Loss on Semaglutide vs Tirzepatide: What the Body Scans Show, and What Strength Training Adds
- How Much Protein on a GLP-1? What the Joint Advisory and Expert Consensus Say
- Stopping Wegovy or Zepbound: How Much Weight Comes Back, and What Happens to Blood Pressure and Blood Sugar
References
- [1]Shedding: An updated guide to a common cause of hair loss. Cleve Clin J Med, 2026.
- [2]ZEPBOUND (tirzepatide) injection: prescribing information (DailyMed, revised 08/2026). U.S. National Library of Medicine (DailyMed), 2026.
- [3]WEGOVY (semaglutide) injection and tablets: prescribing information (DailyMed, revised 06/2026). U.S. National Library of Medicine (DailyMed), 2026.
- [4]GLP-1 therapies and hair loss: A systematic review of current evidence and implications for counseling. Sci Prog, 2026.
- [5]GLP-1 Receptor Agonists and Alopecia: A Systematic Review and Meta-Analysis of Incidence, Risk, Subtypes, and Mechanisms. Skin Appendage Disord, 2026.
- [6]Iron deficiency in female pattern hair loss, chronic telogen effluvium, and control groups. J Am Acad Dermatol, 2010.
- [7]Decreased serum ferritin is associated with alopecia in women. J Invest Dermatol, 2003.